RAPT Therapeutics logo
RAPT Therapeutics, Inc. (RAPT)
Mar 3, 2026 - RAPT was delisted (reason: acquired by GSK)
58.02
0.00 (0.00%)
Inactive · Last trade price on Mar 2, 2026

RAPT Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for RAPT Therapeutics stock had an average target of $56.22, with a low estimate of $9.00 and a high estimate of $80.

Price Target: $56.22 (-3.10%)
Analyst Consensus: Buy

Price Target

TargetLowAverageMedianHigh
Price$9.00$56.22n/a$80
Change-84.49%-3.10%n/a+37.88%

Analyst Ratings

The average analyst rating for RAPT Therapeutics stock from 10 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.64
from -25.49
EPS Next Year
-3.31
from -2.64
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
EPS
-17.53-20.21-20.61-24.37-25.49-2.64-3.31
No. Analysts
-----1111

Revenue Forecast

Revenue202520262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-1.00-1.86
Avg-2.64-3.31
Low-3.47-4.18

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--